Cargando…
MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy
Diabetic retinopathy (DR) is a serious microvascular complication of diabetes and a major cause of blindness in the developing world. Early diabetic retinopathy is characterized by a loss of pericytes and vascular endothelial cells, a breakdown of the blood–retinal barrier, vascular dysfunction and...
Autores principales: | Wang, Yang, Yan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880890/ https://www.ncbi.nlm.nih.gov/pubmed/27225425 http://dx.doi.org/10.1038/srep26909 |
Ejemplares similares
-
Niaspan inhibits diabetic retinopathy-induced vascular inflammation by downregulating the tumor necrosis factor-α pathway
por: Wang, Yang, et al.
Publicado: (2017) -
Relationship of polymorphisms in microRNAs -124 e -126 with diabetic retinopathy in patients with type 2 diabetes
por: Polina, Evelise Regina, et al.
Publicado: (2015) -
MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis
por: Otsubo, Takeshi, et al.
Publicado: (2011) -
Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats
por: Ye, Xinchun, et al.
Publicado: (2013) -
Niaspan Attenuates the Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Type One Diabetic Rats
por: Yan, Tao, et al.
Publicado: (2013)